356 related articles for article (PubMed ID: 33233661)
1. Acrolein: A Potential Mediator of Oxidative Damage in Diabetic Retinopathy.
Alfarhan M; Jafari E; Narayanan SP
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33233661
[TBL] [Abstract][Full Text] [Related]
2. Pathological Role of Unsaturated Aldehyde Acrolein in Diabetic Retinopathy.
Murata M; Noda K; Ishida S
Front Immunol; 2020; 11():589531. PubMed ID: 33193419
[TBL] [Abstract][Full Text] [Related]
3. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction.
Liu Z; Sun L; Zhu L; Jia X; Li X; Jia H; Wang Y; Weber P; Long J; Liu J
J Neurochem; 2007 Dec; 103(6):2690-700. PubMed ID: 20938484
[TBL] [Abstract][Full Text] [Related]
4. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
Narayanan SP; Shosha E; D Palani C
Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
[TBL] [Abstract][Full Text] [Related]
5. Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine.
McDowell RE; Barabas P; Augustine J; Chevallier O; McCarron P; Chen M; McGeown JG; Curtis TM
Diabetologia; 2018 Dec; 61(12):2654-2667. PubMed ID: 30112688
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.
Coucha M; Elshaer SL; Eldahshan WS; Mysona BA; El-Remessy AB
Middle East Afr J Ophthalmol; 2015; 22(2):135-44. PubMed ID: 25949069
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of acrolein toxicity: relevance to human disease.
Moghe A; Ghare S; Lamoreau B; Mohammad M; Barve S; McClain C; Joshi-Barve S
Toxicol Sci; 2015 Feb; 143(2):242-55. PubMed ID: 25628402
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
[TBL] [Abstract][Full Text] [Related]
9. Role of Oxidative Stress in Diabetic Retinopathy and the Beneficial Effects of Flavonoids.
Ola MS; Al-Dosari D; Alhomida AS
Curr Pharm Des; 2018; 24(19):2180-2187. PubMed ID: 29766782
[TBL] [Abstract][Full Text] [Related]
10. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats.
Huang J; Li X; Li M; Li J; Xiao W; Ma W; Chen X; Liang X; Tang S; Luo Y
Curr Mol Med; 2013 Jul; 13(6):935-45. PubMed ID: 23745582
[TBL] [Abstract][Full Text] [Related]
12. Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina.
Al-Dosari DI; Ahmed MM; Al-Rejaie SS; Alhomida AS; Ola MS
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29064407
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
Kang Q; Yang C
Redox Biol; 2020 Oct; 37():101799. PubMed ID: 33248932
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy.
Li C; Miao X; Li F; Wang S; Liu Q; Wang Y; Sun J
Oxid Med Cell Longev; 2017; 2017():9702820. PubMed ID: 28265339
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbial Glycerol Metabolism as an Endogenous Acrolein Source.
Zhang J; Sturla S; Lacroix C; Schwab C
mBio; 2018 Jan; 9(1):. PubMed ID: 29339426
[TBL] [Abstract][Full Text] [Related]
16. Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology.
Cecilia OM; José Alberto CG; José NP; Ernesto Germán CM; Ana Karen LC; Luis Miguel RP; Ricardo Raúl RR; Adolfo Daniel RC
J Diabetes Res; 2019; 2019():8562408. PubMed ID: 31511825
[TBL] [Abstract][Full Text] [Related]
17. Alleviate oxidative stress in diabetic retinopathy: antioxidant therapeutic strategies.
Gao J; Tao L; Jiang Z
Redox Rep; 2023 Dec; 28(1):2272386. PubMed ID: 38041593
[TBL] [Abstract][Full Text] [Related]
18. The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy.
Augustine J; Troendle EP; Barabas P; McAleese CA; Friedel T; Stitt AW; Curtis TM
Front Endocrinol (Lausanne); 2020; 11():621938. PubMed ID: 33679605
[TBL] [Abstract][Full Text] [Related]
19. Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury.
Hamann K; Shi R
J Neurochem; 2009 Dec; 111(6):1348-56. PubMed ID: 19780896
[TBL] [Abstract][Full Text] [Related]
20. Nutraceuticals for the Treatment of Diabetic Retinopathy.
Rossino MG; Casini G
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
